Back to Search
CHRISTINA TOPHAM, MD
MD
Dermatology Physician
NPI: 1316575319IndividualAccepts Medicare
Education
UNIVERSITY OF UTAH SCHOOL OF MEDICINE
Class of 2020
Research & Publications (20)
Orientation preferences of backbone secondary amide functional groups in peptide nucleic acid complexes: quantum chemical calculations reveal an intrinsic preference of cationic D-amino acid-based chiral PNA analogues for the P-form.
PMID 17071666·Biophys J·2007
8-other
On the spatial disposition of the fifth transmembrane helix and the structural integrity of the transmembrane binding site in the opioid and ORL1 G protein-coupled receptor family.
PMID 10906343·Protein Eng·2000
8-other
The kinetic basis of a general method for the investigation of active site content of enzymes and catalytic antibodies: first-order behaviour under single-turnover and cycling conditions.
PMID 10887904·J Theor Biol·2000
7-preclinical
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
PMID 19451431·J Clin Oncol·2009
3-trial
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.
PMID 19451425·J Clin Oncol·2009
3-trial
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.
PMID 17630037·Lancet·2007
4-observational
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.
PMID 17194911·J Clin Oncol·2007
3-trial
A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.
PMID 16622464·Br J Cancer·2006
3-trial
Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients.
PMID 16391786·Int J Oncol·2006
8-other
Once-weekly treatment of anemia in patients with cancer: a comparative review of epoetins.
PMID 16015034·Oncology·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 30 N 1900 E RM 4A330
SALT LAKE CITY, UT 84132 - Phone
- (801) 581-6465
Quick Facts
- NPI
- 1316575319
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile